Related Articles
Prognostic significance of CD117 expression and TP53 missense mutations in triple-negative breast cancer
Genetic predisposition in female patients with triple‑negative breast cancer
The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancer
Integrated analysis of expression profiling data identifies three genes in correlation with poor prognosis of triple-negative breast cancer
Knockdown of E2F5 induces cell death via the TP53‑dependent pathway in breast cancer cells carrying wild‑type TP53